Literature DB >> 18443022

The future of clinical trials evaluating blood substitutes.

Dean A Fergusson, Lauralyn McIntyre.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18443022     DOI： 10.1001/jama.299.19.jed80027

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  3 in total

1.  Dodecafluoropentane emulsion decreases infarct volume in a rabbit ischemic stroke model.

Authors:  William C Culp; Sean D Woods; Robert D Skinner; Aliza T Brown; John D Lowery; Jennifer L H Johnson; Evan C Unger; Leah J Hennings; Michael J Borrelli; Paula K Roberson
Journal:  J Vasc Interv Radiol       Date:  2011-11-12       Impact factor: 3.464

2.  Efficacy of the perfluorocarbon dodecafluoropentane as an adjunct to pre-hospital resuscitation.

Authors:  Alicia M Bonanno; Todd L Graham; Lauren N Wilson; Brianne M Madtson; James D Ross
Journal:  PLoS One       Date:  2018-11-29       Impact factor: 3.240

Review 3.  Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials.

Authors:  Manoj M Lalu; Lauralyn McIntyre; Christina Pugliese; Dean Fergusson; Brent W Winston; John C Marshall; John Granton; Duncan J Stewart
Journal:  PLoS One       Date:  2012-10-25       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.